- Home
- TGLS vs HCM Comparison
TGLS vs HCM Comparison
Compare TGLS & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TGLS | HCM |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | Colombia | Hong Kong |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | TGLS | HCM |
|---|---|---|
| Price | $51.89 | $13.23 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $80.00 | $13.75 |
| AVG Volume (30 Days) | ★ 442.0K | 22.8K |
| Earning Date | 11-06-2025 | 08-07-2025 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 20.09 | N/A |
| EPS | ★ 3.84 | 0.53 |
| Revenue | ★ $977,886,000.00 | $602,197,000.00 |
| Revenue This Year | $12.20 | N/A |
| Revenue Next Year | $10.73 | $15.54 |
| P/E Ratio | $13.23 | ★ $4.98 |
| Revenue Growth | ★ 15.70 | N/A |
| 52 Week Low | $44.26 | $11.51 |
| 52 Week High | $90.34 | $19.50 |
Technical Indicators
Market Signals| Indicator | TGLS | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 32.24 |
| Support Level | $50.70 | $13.06 |
| Resistance Level | $54.73 | $13.79 |
| Average True Range (ATR) | 1.46 | 0.22 |
| MACD | 0.49 | -0.04 |
| Stochastic Oscillator | 55.81 | 24.99 |
Price Performance
Historical ComparisonAbout TGLS Tecnoglass Inc.
Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.